Edition:
United Kingdom

Profile: RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

1,568JPY
4:45am BST
Change (% chg)

¥-4 (-0.25%)
Prev Close
¥1,572
Open
¥1,567
Day's High
¥1,584
Day's Low
¥1,547
Volume
199,900
Avg. Vol
1,940,206
52-wk High
¥2,210
52-wk Low
¥785

RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion partial agonist, among others.

Company Address

RaQualia Pharma Inc

8F, Daiwa Meieki Bldg.
1-21-19, Meieki-Minami
Nakamura-ku
NAGOYA-SHI   ACH   450-0003
P: +8152.4466100

Company Web Links